Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 840-847, February 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bae, I.
Right arrow Articles by Fornace, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bae, I.
Right arrow Articles by Fornace, A. J., Jr.

An Abnormality in the p53 Pathway following {gamma}-Irradiation in Many Wild-Type p53 Human Melanoma Lines

Insoo Bae1, Martin L. Smith, M. Saeed Sheikh, Qimin Zhan, Dominic A. Scudiero, Stephen H. Friend2, Patrick M. O'Connor and Albert J. Fornace, Jr.3

Laboratory of Molecular Pharmacology, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, NIH, Maryland 20892 [I. B., M. L. S., M. S. S., Q. Z. P. M. O., A. J. F.]; Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 [D. A. S.]; and Massachusetts General Hospital, Cancer Center, Charlestown, Massachusetts 02129 [S. H. F.]

DNA-damaging agents such as ionizing radiation (IR) activate the tumor suppressor p53, and, in turn, p53 transactivates a number of downstream effector genes such as GADD45, CIP1/WAF1, and MDM2. The induction of these downstream genes following IR appears to be strictly dependent upon the presence of wild-type functional p53 known to evoke G1 arrest. In this study, we characterized 56 cell lines from 9 different tumor types with predetermined p53 genotype by measuring the induction of GADD45, CIP1/WAF1, and MDM2 relative mRNA levels after IR. A higher fraction of melanoma lines had wild-type (wt) p53 (5/8, or 63%) compared to the nonmelanoma lines (11/48, or 23%). Most wt p53 (nonmelanoma) cell lines (11/12, or 92%) showed clear induction of both GADD45 and CIP1/WAF1. On the other hand, many wt p53 melanoma lines (4/5, or 80%) showed normal induction of CIP1/WAF1, but little or no induction of GADD45. Despite this defect in GADD45 induction, we found that all wt p53 melanoma lines exhibited strong G1 arrest and increased levels of p53 protein after IR. The results demonstrated that radiation-induced G1 arrest could occur by the p53-CIP1/WAF1 pathway without appreciable induction of GADD45 in melanoma lines. Time course experiments demonstrated prolonged induced expression of CIP1/WAF1 mRNA transcripts in melanoma lines in which GADD45 induction was lacking, suggesting some sort of compensatory mechanism involving CIP1/WAF1, in cell lines with defective GADD45 induction. We could reproduce this compensatory effect in RKO colon carcinoma cells in which GADD45 expression was blocked by constitutive antisense vectors. These findings reveal that defective induction of GADD45 following IR is common in human melanoma cell lines.

1 Present address: Fels Institute for Cancer Research and Molecular Biology, Temple University of School Medicine, Philadelphia, PA 19140.

2 Present address: Hutchinson Cancer Center, University of Washington, Seattle, WA.

3 To whom requests for reprints should be addressed, at Laboratory of Molecular Pharmacology, National Cancer Institute, NIH, Building 37, Room 5C09, Bethesda, MD 20892.

Received 6/29/95. Accepted 12/15/95.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. A. Amundson, K. T. Do, L. C. Vinikoor, R. A. Lee, C. A. Koch-Paiz, J. Ahn, M. Reimers, Y. Chen, D. A. Scudiero, J. N. Weinstein, et al.
Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen
Cancer Res., January 15, 2008; 68(2): 415 - 424.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. S.M. Smalley, R. Contractor, N. K. Haass, A. N. Kulp, G. E. Atilla-Gokcumen, D. S. Williams, H. Bregman, K. T. Flaherty, M. S. Soengas, E. Meggers, et al.
An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells
Cancer Res., January 1, 2007; 67(1): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Sun, B. N. Tran, L. A. Worley, R. B. Delston, and J. W. Harbour
Functional Analysis of the p53 Pathway in Response to Ionizing Radiation in Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1561 - 1564.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
R. Pal, A. Datta, A. J. Fornace Jr, M. L. Bittner, and E. R. Dougherty
Boolean relationships among genes responsive to ionizing radiation in the NCI 60 ACDS
Bioinformatics, April 15, 2005; 21(8): 1542 - 1549.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Bucci, I. D'Agnano, D. Amendola, A. Citti, G. H. Raza, R. Miceli, U. De Paula, R. Marchese, S. Albini, A. Felsani, et al.
Myc Down-Regulation Sensitizes Melanoma Cells to Radiotherapy by Inhibiting MLH1 and MSH2 Mismatch Repair Proteins
Clin. Cancer Res., April 1, 2005; 11(7): 2756 - 2767.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. Amundson, M. B. Grace, C. B. McLeland, M. W. Epperly, A. Yeager, Q. Zhan, J. S. Greenberger, and A. J. Fornace Jr.
Human In vivo Radiation-Induced Biomarkers: Gene Expression Changes in Radiotherapy Patients
Cancer Res., September 15, 2004; 64(18): 6368 - 6371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-H. Tang and E. A. Grimm
Depletion of Endogenous Nitric Oxide Enhances Cisplatin-induced Apoptosis in a p53-dependent Manner in Melanoma Cell Lines
J. Biol. Chem., January 2, 2004; 279(1): 288 - 298.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. A. Amundson, R. A. Lee, C. A. Koch-Paiz, M. L. Bittner, P. Meltzer, J. M. Trent, and A. J. Fornace Jr
Differential Responses of Stress Genes to Low Dose-Rate {gamma} Irradiation
Mol. Cancer Res., April 1, 2003; 1(6): 445 - 452.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. S. Rieber, U. Zangemeister-Wittke, and M. Rieber
p53-independent Induction of Apoptosis in Human Melanoma Cells by a bcl-2/bcl-xL Bispecific Antisense Oligonucleotide
Clin. Cancer Res., May 1, 2001; 7(5): 1446 - 1451.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. A. Amundson, T. G. Myers, D. Scudiero, S. Kitada, J. C. Reed, and A. J. Fornace Jr.
An Informatics Approach Identifying Markers of Chemosensitivity in Human Cancer Cell Lines
Cancer Res., November 1, 2000; 60(21): 6101 - 6110.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
K. Satyamoorthy, N. H. Chehab, M. J. F. Waterman, M. C. Lien, W. S. El-Deiry, M. Herlyn, and T. D. Halazonetis
Aberrant Regulation and Function of Wild-Type p53 in Radioresistant Melanoma Cells
Cell Growth Differ., September 1, 2000; 11(9): 467 - 474.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
F. Carrier, P. T. Georgel, P. Pourquier, M. Blake, H. U. Kontny, M. J. Antinore, M. Gariboldi, T. G. Myers, J. N. Weinstein, Y. Pommier, et al.
Gadd45, a p53-Responsive Stress Protein, Modifies DNA Accessibility on Damaged Chromatin
Mol. Cell. Biol., March 1, 1999; 19(3): 1673 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
T. Haapajärvi, K. Pitkänen, and M. Laiho
Human Melanoma Cell Line UV Responses Show Independency of p53 Function
Cell Growth Differ., March 1, 1999; 10(3): 163 - 171.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Fiscella, H. Zhang, S. Fan, K. Sakaguchi, S. Shen, W. E. Mercer, G. F. Vande Woude, P. M. O'Connor, and E. Appella
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner
PNAS, June 10, 1997; 94(12): 6048 - 6053.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.